Home / Meetings and Events

ABOUT CASSS MEETINGS

CASSS meetings bring together industry, regulatory, and academic professionals for critical discussions to solve technical and regulatory challenges in the field of biopharmaceutical development. CASSS Symposia and Fora provide venues for biopharmaceutical professionals to: 

  • Connect with a relevant global network.
  • Gain tangible knowledge for career advancement.
  • Learn best practices from prominent contributors in the industry.

  • Image with hexagons and text 'CMC Strategy Forum North America Advancing Biopharmaceutical Development' CMC Strategy Forum North America
    January 27, 2025

    The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

  • Image of purple background with text 'WCBP' WCBP
    January 28 to 30, 2025

    The WCBP Symposium addresses the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives.

  • Image with text 'bioassays scientific approaches and regulatory strategies' Bioassays
    April 7 to 9, 2025

    The CASSS Bioassays Symposium presents an opportunity to discuss current perspectives, strategies, and technologies used for bioassays.

  • Blue graphic with text 'mRNA Therapy Products' Symposium on mRNA
    May 29 to 30, 2025

    The NEW Symposium on mRNA explores how mRNA has become a new modality and how mRNA vaccines are applied.

  • Image of DNA helix with text 'CGTP Summit' CGTP Summit
    June 9, 2025

    This one-day Summit is designed to discuss pertinent challenges in the cell and gene therapy field through speaker presentations with interactive, in-depth panel discussions.

  • Image of DNA helix with text 'Cell & Gene Therapy Products Manufacturing, Quality and Regulatory Considerations' Cell and Gene Therapy Products
    June 10 to 12, 2025

    The Symposium will bring together industry, regulatory, and academic professionals to discuss pertinent challenges in the cell and gene therapy field.

  • Image with hexagons and text 'CMC Strategy Forum North America Advancing Biopharmaceutical Development' CMC Strategy Forum North America
    July 14 to 15, 2025

    The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

  • CMC Strategy Forum Latin America CMC Strategy Forum Latin America Session I
    August 13, 2025

    The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.

  • CMC Strategy Forum Latin America CMC Strategy Forum Latin America Session II
    August 20, 2025

    The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.

  • CE in the Biotechnology & Pharmaceutical Industries CE Pharm
    September 7 to 10, 2025

    The Symposium provides a forum for the discussion of recent developments in capillary electrophoresis (CE) analysis of protein, nucleotide, and small molecule pharmaceuticals.

  • Red orange background with hexagon molecules and text 'Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry' Mass Spectrometry
    September 23 to 26, 2025

    The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry.

  • Image of dark blue background with text 'CMC Strategy Forum Europe' CMC Strategy Forum Europe
    October 20 to 22, 2025

    Adhering to the established CMC Forum series model, the Forum highlights topics and regulatory updates pertinent to Europe.

  • Image with text 'cmc strategy forum japan advancing biopharmaceutical development' CMC Strategy Forum Japan
    December 8 to 9, 2025

    Adhering to the established CMC Forum series model, the Forum highlights topics and regulatory updates pertinent to Japan and the Asia/Pacific Region.

Fast Facts

  • Annually, CASSS holds 15 scientific, multi-day Symposia, Fora, and Discussion Groups around the world.
  • Attendees represent 30 regulatory agencies and 440 biopharmaceutical companies.
  • Members reside in 46 countries throughout North America, Europe, Asia, Africa, and South America.

Code of Conduct

CASSS is committed to providing a safe, productive, and welcoming environment for all meeting participants and CASSS staff. All participants, including, but not limited to, attendees, speakers, volunteers, industry, partners, exhibitors, CASSS staff members, service providers, and all others are expected to abide by this Code of Conduct.

View Code of Conduct